Bizarre Patents
Safety System For Remove a Rider From a Vehicle by Deploying a Parachute
Methods and apparatus for reducing the velocity of a rider in or on an open cockpit vehicle when the rider is thrown from the vehicle.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6406873 | PAI-2 and T-PA as diagnostic markers of periodontal disease The existence and the extent of periodontal disease can be diagnosed by measuring plasminogen activator inhibitor 2 (PAI-2) and/or tissue plasminogen activator (t-PA) levels in gingival crevicular fluid (GCF). Levels of PAI-2 and t-PA in GCF rise sharply ... | 06/18/2002 |
| 6344189 | Use of protease inhibitors for treating skin wounds The healing of chronic wounds, such as leg ulcers, is accelerated via topical administration of a serine protease inhibitor, such as PAI-2. Wound healing also is promoted using combinations of protease inhibitors, such as PAI-2 with other serine protease ... | 02/05/2002 |
| 6288025 | Protease inhibitors for use in the treatment of psoriasis Psoriasis may be treated by topical administration of a urokinase inhibitor, such as PAI-2, or a combination of protease inhibitors, such as PAI-2 with other serine protease inhibitors and/or with protease inhibitors such as inhibitors of metalloproteinas... | 09/11/2001 |
| 6221397 | Surface cross-linked particles suitable for controlled delivery Cross-linked particles are provided that are useful for delivery of pharmaceutical agents. The particles comprise at least one polymeric compound and a spacer compound, where the polymeric compound and the spacer each comprise reactive carboxyl, hydrazidy... | 04/24/2001 |
| 6150341 | Vitamin B12 derivatives and methods for their preparation This invention relates to methods for preparing vitamin B12 (VB12) derivatives suitable for linking to a polymer, nanoparticle or therapeutic agent, protein or peptide. The methods involve reacting the 5'OH group of VB12 o... | 11/21/2000 |
| 5942413 | Nematode vaccine Disclosed is a substantially purified antigen derived from a first species of parasitic nematodes, which antigen is capable of providing protection to a host from parasitism infestation by a second nematode species, which may be the same as or different f... | 08/24/1999 |
| 5928644 | T-cell epitopes T-cell epitopes of or derived from the TraT protein of E. coli have been identified and used in the preparation of complexes with immunogens to enhance or provide immune responses to the immunogens. The complexes can be prepared directly, by chemical link... | 07/27/1999 |
| 5863900 | Lhrh antagonists The present invention provides novel LHRH antagonists and complexes between these antagonists and VB12. The present invention is particularly useful for the oral administration of LHRH antagonists. The antagonists of the invention are selected from the gr... | 01/26/1999 |
| 5807832 | Oral delivery of biologically active substances bound to vitamin B12 Complex of a drug, hormone, bio-active peptide, or immunogen with the carrier molecule vitamin B12 and a method for delivering the complex to the intestine of a host vertebrate in order to deliver the complex to the circulation of the host and thereby eli... | 09/15/1998 |
| 5734035 | Nematode vaccine Disclosed is a substantially purified antigen derived from a first parasitic nematode species which, when administered to a host animal, is capable of protecting the host animal from infestation by a second parasitic mematode species, wherein the first an... | 03/31/1998 |
| 5548064 | Vitamin B12 conjugates with EPO, analogues thereof and pharmaceutical compositions The invention describes complexes between VB12 analogues and either GCSF or EPO that retain both significant affinity for intrinsic factor (IF) in the VB12 portion of the complex and significant bioactivity of the GCSF or EPO portion... | 08/20/1996 |
| 5525508 | Haemonchus contortus vaccine A substantially purified antigen derived from a first species of parasitic nematodes, which antigen is capable of providing protection to a host from parasitism by a second nematode species, which may be the same as or different from the first nematode sp... | 06/11/1996 |
| 5500366 | Polynucleotide encoding T-cell epitopes of the protein TraT T-cell epitopes of or derived from the TraT protein of E. coli have been identified and used in the preparation of complexes with immunogens to enhance or provide immune responses to the immunogens. The complexes can be prepared directly, by chemical link... | 03/19/1996 |
| 5449720 | Amplification of the VB12 uptake system using polymers The invention relates to the oral delivery of peptide and protein pharmaceuticals using the vitamin B12 (VB12) uptake system, with the delivery being amplified using polymers. More particularly, the invention concerns a complex havin... | 09/12/1995 |
| 5444153 | Variants of PAI-2 Variants of the plasminogen activator inhibitor PAI-2 in which the 66-98 amino acid residue region has been altered to eliminate at least one protease sensitive site are provided. The variants of the invention maintain the biological activity of PAI-2 and... | 08/22/1995 |
